Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Apr 7, 2026
Reporting period
Not applicable
Filed with the SEC
Apr 9, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001368324-26-000004
Filed / recorded
Apr 9, 2026, 9:15 PM UTC
Added to OQRO
Oct 7, 2026, 5:52 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Ovid Therapeutics Inc.
Issuer CIK
1636651
Ticker
OVID
Reporting person
Bart Friedman
Relationship
Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Apr 7, 2026
Transaction code
A
Shares / units
8,789
Price per share
$2.56
Acquired / disposed
Acquired (A)
Shares owned after
8,789
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents a restricted stock unit ("RSU") award issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of 50% of an annual cash retainer for service on the Issuer's Board of Directors in the aggregate amount of $22,500. The RSUs vest 25% upon grant and 25% on each of June 30, 2026, September 30, 2026 and December 31, 2026, subject to the Reporting Person's continuous service through each such vesting date.